GHK-Cu 125mg Research Peptide
GHK-Cu (Copper peptide GHK-Cu, glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide found in human plasma, saliva, and urine that binds copper(II) with high affinity. First isolated from human plasma albumin by Loren Pickart in 1973, GHK-Cu has been studied for its roles in wound healing, tissue remodeling, anti-inflammatory effects, and gene expression modulation. This 125mg bulk vial provides research-grade GHK-Cu at ≥99% purity, suitable for extended laboratory protocols.
Research Background
GHK-Cu has one of the most extensively studied gene expression profiles of any peptide compound — microarray studies by Pickart and colleagues identified that GHK-Cu modulates over 4,000 human genes, including upregulation of tissue repair genes and downregulation of inflammatory and cancer-associated pathways. Research applications span dermal wound healing models, bone density research, nerve regeneration, and anti-senescence gene expression studies.
Compound Specifications
- Format: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Quantity: 125mg per vial
- Storage: −20°C, protected from light
- Molecular Formula: C₁₄H₂₄CuN₆O₄
- Molecular Weight: 403.9 Da
Certificate of Analysis
All GHK-Cu vials are third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
